Ajooni Biotech (NSE:AJOONI) Additional Paid-In Capital: ₹432 Mil(As of Mar. 2025)


NSE:AJOONI Ajooni Biotech Ltd NSE:AJOONI
63 GF Score
Price ₹3.68
View Full Analysis

What is Ajooni Biotech Additional Paid-In Capital?

Ajooni Biotech NSE:AJOONI -0.81% 63 Additional Paid-In Capital is ₹432 Mil as of Mar. 2025. GuruFocus rates NSE:AJOONI with a GF Score™ of 63/100.


Ajooni Biotech's quarterly additional paid-in capital stayed the same from Sep. 2024 (₹0 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹432 Mil).

Ajooni Biotech's annual additional paid-in capital stayed the same from Mar. 2023 (₹178 Mil) to Mar. 2024 (₹178 Mil) but then increased from Mar. 2024 (₹178 Mil) to Mar. 2025 (₹432 Mil).

Ajooni Biotech Additional Paid-In Capital Related Terms

Ajooni Biotech Additional Paid-In Capital Historical Data

* Premium members only.

The historical data trend for Ajooni Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajooni Biotech Additional Paid-In Capital Chart

Ajooni Biotech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 177.97 177.97 431.86

Ajooni Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 177.97 0.00 0.00 0.00 431.86
NSE:AJOONI
63GF Score
Ajooni Biotech Ltd NSE:AJOONI
Additional Paid-In Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ajooni Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)
What does a Additional Paid-In Capital of ₹432 Mil mean?
Ajooni Biotech (NSE:AJOONI) has a Additional Paid-In Capital of ₹432 Mil as of Mar. 2025. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Ajooni Biotech and its competitors.
Is Ajooni Biotech's Additional Paid-In Capital too high?
Ajooni Biotech's current Additional Paid-In Capital is ₹432 Mil. Overall, Ajooni Biotech has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Ajooni Biotech's Additional Paid-In Capital compare to KHC and GIS?
Ajooni Biotech's Additional Paid-In Capital of ₹432 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Additional Paid-In Capital for a Consumer Packaged Goods company?
A good Additional Paid-In Capital depends on the Consumer Packaged Goods industry context. However, Additional Paid-In Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Additional Paid-In Capital mean?
A high Additional Paid-In Capital can signal that a stock is expensive relative to its fundamentals. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Ajooni Biotech and its competitors. Ajooni Biotech's current Additional Paid-In Capital is ₹432 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajooni Biotech stock overvalued right now?
Ajooni Biotech (NSE:AJOONI) has a current Additional Paid-In Capital of ₹432 Mil. The current Additional Paid-In Capital is ₹432 Mil. Ajooni Biotech's overall GF Score™ is 63/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Additional Paid-In Capital calculated?
Additional Paid-In Capital is calculated from a company's financial statements. For Ajooni Biotech (NSE:AJOONI), the current Additional Paid-In Capital is ₹432 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ajooni Biotech Business Description

Address House No. 1769, Phase 3B2, Mohali, PB, IND, 160055
Ajooni Biotech Ltd is engaged in providing animal health care solutions dedicated to improving the productivity of Dairy farmers and sustainably increasing livestock yields. The company's products of cattle feed include Gold Pashu Aahar, Buff Plus, 3 Star, 4 Star, Calf Starter, & Transition Plus, and its feed supplements include Calvit, Batisa, Liv, Min, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.
63GF Score

Get the complete analysis for NSE:AJOONI

Additional Paid-In Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.68
Price